B G Baumert
Overview
Explore the profile of B G Baumert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
676
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Friker L, Tzaridis T, Enkirch S, Luders C, Hattingen E, Kristiansen G, et al.
Pathol Res Pract
. 2023 Mar;
244:154399.
PMID: 36905695
Gliosarcoma is a rare histopathological subtype of glioblastoma. Metastatic spreading is unusual. In this report, we illustrate a case of gliosarcoma with extensive extracranial metastases with confirmation of histological and...
2.
Gao Y, Weenink B, van den Bent M, Erdem-Eraslan L, Kros J, Sillevis Smitt P, et al.
Eur J Cancer
. 2018 Mar;
94:168-178.
PMID: 29571083
Introduction: The European Organisation for Research and Treatment of Cancer (EORTC) 22033-26033 clinical trial (NCT00182819) investigated whether initial temozolomide (TMZ) chemotherapy confers survival advantage compared with radiotherapy (RT) in low-grade...
3.
Kaidar-Person O, Meattini I, Jain P, Bult P, Simone N, Kindts I, et al.
Breast Cancer Res Treat
. 2017 Oct;
167(2):479-483.
PMID: 28975433
Purpose: Discordances between the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), expression between primary breast tumors and their subsequent brain metastases (BM) were...
4.
Allal A, Ares C, Dulguerov P, Tschanz E, Verdan C, Mhawech P, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:89-108.
PMID: 27137923
No abstract available.
5.
Mack F, Baumert B, Schafer N, Hattingen E, Scheffler B, Herrlinger U, et al.
Cancer Treat Rev
. 2016 Feb;
43:83-91.
PMID: 26827696
Leptomeningeal metastasis (LM), i.e. the seeding of tumor cells to the cerebrospinal fluid (CSF) and the leptomeninges, is a devastating and mostly late-stage complication of various solid tumors. Clinical signs...
6.
Compter I, Zaugg K, Houben R, Dings J, Bosmans G, Buescher C, et al.
Strahlenther Onkol
. 2012 Sep;
188(10):887-93.
PMID: 22961046
Purpose: The goal of the present study was to analyze long-term results of fractionated stereotactic radiotherapy (SRT) in patients with a meningioma. Methods And Materials: A total of 72 patients...
7.
Theelen A, Martens J, Bosmans G, Houben R, Jager J, Rutten I, et al.
Strahlenther Onkol
. 2011 Dec;
188(1):84-90.
PMID: 22194025
Purpose: The goal was to provide a quantitative evaluation of the accuracy of three different fixation systems for stereotactic radiotherapy and to evaluate patients' acceptance for all fixations. Methods: A...
8.
Mul V, de Jong J, Murrer L, van den Ende P, Houben R, Lacko M, et al.
Strahlenther Onkol
. 2011 Dec;
188(1):71-6.
PMID: 22194023
Background And Purpose: The goal of this work was to examine toxicity and risk factors after irradiation of the cervical spinal cord. Patients And Methods: A total of 437 patients...
9.
Brandes A, Franceschi E, Gorlia T, Wick W, Jacobs A, Baumert B, et al.
Eur J Cancer
. 2011 Nov;
48(6):896-903.
PMID: 22119352
The progression-free survival rate at 6 months (PFS-6) has long been considered the best end-point for assessing the efficacy of new agents in phase II trials in patients with recurrent...
10.
van den Bent M, Wefel J, Schiff D, Taphoorn M, Jaeckle K, Junck L, et al.
Lancet Oncol
. 2011 Apr;
12(6):583-93.
PMID: 21474379
Although low-grade gliomas (LGG) have a less aggressive course than do high-grade gliomas, the outcome of these tumours is ultimately fatal in most patients. Both the tumour and its treatment...